Etobrosmin 84.7mg/25.3mg Injection may cause excessive drowsiness and calmness with alcohol.

Etobrosmin 84.7mg/25.3mg Injection may be unsafe to use during pregnancy.Animal studies have shown adverse effects on the foetus, however, there are limited human studies. The benefits from use in pregnant women may be acceptable despite the risk. Please consult your doctor.

Etobrosmin 84.7mg/25.3mg Injection is safe to use during lactation. Human studies have shown that either the drug does not pass into the breastmilk in significant amount or is not expected to cause toxicity to the baby.Avoiding breastfeeding for 2-4 hours after Etobrosmin 84.7mg/25.3mg Injection can further decrease the exposure of medicine to the baby.

It is not known whether Etobrosmin 84.7mg/25.3mg Injection alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react.

There is limited information available on the use of Etobrosmin 84.7mg/25.3mg Injection in patients with kidney disease. Please consult your doctor.

Etobrosmin 84.7mg/25.3mg Injection should be used with caution in patients with liver disease. Dose adjustment of Etobrosmin 84.7mg/25.3mg Injection may be needed. Please consult your doctor.